Arrowhead Pharmaceuticals In

ARWR13F as of Jun 30, 2026 · next update ~Nov 14

Limited coverage

Only 1 fund we track owns this stock, so quarterly sentiment and aggregates may be sparse.

Who's buying ARWR

Top funds mostly added to Arrowhead Pharmaceuticals In in Q2 (Apr⁠–⁠Jun)

Buying:

Funds1InsidersCongress

Top funds
1 of 1 bought more, 0 sold some. Largest: Polen Capital Management, $539K (0% of its portfolio).
Insiders
No buys, 19 sales in 12 months.
Congress
No trades disclosed in the last 12 months.

1 fund$538,944 held0.0% avg. weightQ2: 1 bought / 0 sold

13F reports are a snapshot as of Jun 30, 2026; funds may have traded since. Insiders often sell for personal reasons (taxes, diversification, planned sales).

Share price · market data, not from 13F reports

Q2 2026

Insider trades (Form 4)

Last 2 years · 37 filings

Date	Insider	Type	Shares	Price	Value
Aug 18, 2026	Adeoye Y Olukotun Director	Sold	2,000	$86.96	$174K
Aug 18, 2026	Michael S Perry Director	Sold	11,600	$87.30	$1.01M
May 12, 2026	Hongbo LU Director	Sold	2,970	$76.88	$228K
Apr 22, 2026	Daniel Joseph Apel CFO	Sold	13,095	$71.35	$934K
Apr 23, 2026	James C Hamilton	Sold	10,000	$75.00	$750K
Mar 5, 2026	James C Hamilton	Sold	10,000	$64.19	$642K
Jan 5, 2026	Patrick O'brien COO	Sold	49,493	$63.11	$3.12M
Jan 5, 2026	James C Hamilton	Sold	40,164	$63.11	$2.53M
Jan 2, 2026	Christopher Richard Anzalone CEO	Sold	13,187	$66.10	$872K
Dec 29, 2025	Christopher Richard Anzalone CEO	Sold	51,726	$69.13	$3.58M
Dec 26, 2025	Mauro Ferrari Director	Sold	7,530	$70.00	$527K
Dec 19, 2025	William D. Waddill Director	Sold	8,367	$67.65	$566K
Dec 19, 2025	Victoria Vakiener Director	Sold	10,040	$67.68	$679K
Dec 19, 2025	Christopher Richard Anzalone CEO	Sold	26,031	$68.04	$1.77M
Dec 19, 2025	Adeoye Y Olukotun Director	Sold	10,000	$67.66	$677K
Dec 17, 2025	Christopher Richard Anzalone CEO	Sold	85,000	$64.04	$5.44M
Dec 15, 2025	Christopher Richard Anzalone CEO	Sold	184,298	$67.00	$12.35M
Dec 5, 2025	Michael S Perry Director	Sold	16,250	$61.03	$992K
Nov 28, 2025	Mauro Ferrari Director	Sold	8,750	$56.39	$493K
Oct 1, 2025	James C Hamilton	Sold	20,000	$35.00	$700K
Sep 12, 2025	James C Hamilton	Sold	15,000	$30.00	$450K
Sep 2, 2025	James C Hamilton	Sold	15,000	$25.00	$375K
Aug 13, 2025	James C Hamilton	Sold	10,000	$20.00	$200K
Apr 9, 2025	Christopher Richard Anzalone CEO	Sold	141,122	$10.87	$1.53M
Mar 13, 2025	Christopher Richard Anzalone CEO	Sold	51,425	$15.07	$775K
Mar 3, 2025	Christopher Richard Anzalone CEO	Sold	300,000	$17.58	$5.27M
Jan 23, 2025	Adeoye Y Olukotun Director	Sold	959	$21.00	$20K
Jan 6, 2025	James C Hamilton	Sold	32,729	$19.82	$649K
Jan 6, 2025	Patrick O'brien COO	Sold	37,184	$19.80	$736K
Jan 6, 2025	Kenneth Allen Myszkowski CFO	Sold	45,167	$19.77	$893K
Jan 2, 2025	Christopher Richard Anzalone CEO	Sold	11,520	$19.05	$219K
Dec 27, 2024	Adeoye Y Olukotun Director	Sold	2,850	$20.00	$57K
Dec 23, 2024	Christopher Richard Anzalone CEO	Sold	12,563	$19.59	$246K
Dec 18, 2024	Christopher Richard Anzalone CEO	Sold	26,712	$21.24	$567K
Dec 16, 2024	William D. Waddill Director	Sold	7,495	$21.97	$165K
Dec 16, 2024	Douglas B Given Director	Sold	5,547	$21.91	$122K
Dec 16, 2024	Victoria Vakiener Director	Sold	8,994	$21.91	$197K